PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$159.12
-2.94 (-1.81%)
▼
5d:
-1.5%
30d:
+6.66%
90d:
-19.56%
BUY
HIGH Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PODD appears deeply undervalued. Market expects -13.9% annual earnings decline despite 159% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: PODD appears deeply undervalued. Market expects -13.9% annual earnings decline despite 159% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$388.64
Based on 14.3% avg growth
INTRINSIC VALUE TODAY
$241.32
34.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $159.12, which is considered slightly high relative to its 30-day fair value range of $147.10 to $160.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.7) compared to its historical average (30.9). Remarkably, the market is currently pricing in an annual earnings decline of 13.9% over the next few years. This pessimistic expectation contrasts with the company's recent 159.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. Immediate support is located at $152.16, while resistance sits at $167.82.
Market Sentiment: PODD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $238.67 (+50.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PODD is in a strong downtrend. Immediate support is located at $152.16, while resistance sits at $167.82.
Market Sentiment: PODD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $238.67 (+50.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$147.10 -
$160.33
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.0% below Wall St target ($238.67)
Trading Range Analysis
30-Day Trading Range
$147.10 -
$160.33
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$152.16
Resistance Level
$167.82
Current Trend
Strong Downtrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.72
Wall Street Target
$238.67
(+50.0%)
Revenue Growth (YoY)
33.9%
Earnings Growth (YoY)
159.0%
Profit Margin
10.4%
Valuation Discount vs History
-13.9% cheaper
PE vs Historical
19.7 vs 30.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.9%
(market-implied from PE analysis)
1-Year Target
$143.21
(-10%)
2-Year Target
$128.89
(-19%)
3-Year Target
$116.00
(-27%)
3-Yr Target (if PE normalizes)
(PE: 20→31)
$181.72
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 24.5%)
$339.08
(+113%)
Base:
(SPY PE: 19.7, Growth: 24.5%)
$307.08
(+93%)
Bear:
(PE: 16.8, Growth: 24.5%)
$261.02
(+64%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 37.77 | Current EPS (TTM): $4.27
Bull Case
$335.16
(+111%)
Analyst growth 88.9%, PE expands to 41.6
Base Case
$304.69
(+92%)
Market implied 88.9%, PE stable at 37.8
Bear Case
$109.67
(-31%)
Severe decline -20.0%, PE contracts to 32.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.7 to 30.9
Stabilization Target:
$249.27
(+56.7%)
PE Expansion Potential:
+56.7%
Share & Embed Analysis
Last updated: July 14, 2026 6:37 PM ET
Data refreshes hourly during market hours. Next update: 7:37 PM
Data refreshes hourly during market hours. Next update: 7:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael R Minogue
BUY
2030 shares
2026-02-25
Ro Khanna
SELL
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 57 HOLD |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
